Patents by Inventor Armin Buschauer

Armin Buschauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
    Patent number: 10526290
    Abstract: The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: January 7, 2020
    Assignee: SYNBIAS PHARMA AG
    Inventors: Helmut Schickaneder, Christian Schickaneder, Armin Buschauer, Stefan Huber, Michael Limmert, Günther Bernhardt, Mathias Lubbe, Harald Hofmeier
  • BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF IN CANCER THERAPY
    Publication number: 20150152066
    Abstract: The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 4, 2015
    Applicant: Helmut Schickaneder
    Inventors: Helmut Schickaneder, Christian Schickaneder, Armin Buschauer, Stefan Huber, Michael Limmert, Günther Bernhardt, Mathias Lubbe, Harald Hofmeier
  • Esters of bendamustine and related compounds, and medical use thereof
    Patent number: 8809549
    Abstract: The present invention relates to particular esters of bendamustine and related compounds, and medical uses thereof.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: August 19, 2014
    Inventors: Helmut Schickaneder, Armin Buschauer, Guenther Bernhardt, Christian Schickaneder, Michael Limmert, Stefan Huber
  • Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
    Patent number: 8785431
    Abstract: The present invention relates to diester prodrugs of cilazaprilate which undergo enzymatic cleavage to release the active metabolite cilazaprilate that is used for the treatment of hypertension and congestive heart failure. Furthermore the diester prodrugs of cilazaprilate possess all the properties necessary to be topically administered, preferably via transdermal therapeutic systems.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: July 22, 2014
    Assignee: Hexal AG
    Inventors: Günther Bernhardt, Miriam Ertel, Armin Buschauer, Jörg Nink
  • PRODRUGS OF (1S,9S)-9-[[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO]OCTAHYDRO-10-OXO-6H-PYRIDAZINO[1,2-A][1,2]DIAZEPINE-1-CARBOXYLIC ACID AND THEIR USE IN TRANSDERMAL THERAPEUTIC SYSTEMS
    Publication number: 20140147477
    Abstract: The present invention relates to diester prodrugs of cilazaprilate which undergo enzymatic cleavage to release the active metabolite cilazaprilate that is used for the treatment of hypertension and congestive heart failure. Furthermore the diester prodrugs of cilazaprilate possess all the properties necessary to be topically administered, preferably via transdermal therapeutic systems.
    Type: Application
    Filed: June 20, 2012
    Publication date: May 29, 2014
    Applicant: HEXAL AG
    Inventors: Günther Bernhardt, Miriam Ertel, Armin Buschauer, Jörg Nink
  • ESTERS OF BENDAMUSTINE AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF
    Publication number: 20130289032
    Abstract: The present invention relates to particular esters of bendamustine and related compounds, and medical uses thereof.
    Type: Application
    Filed: April 25, 2013
    Publication date: October 31, 2013
    Inventors: Helmut SCHICKANEDER, Armin Buschauer, Guenther Bernhardt, Christian Schickaneder, Michael Limmert, Stefan Huber
  • Pyridyl alkylamine compounds which are useful against histamine H.sub.1 and H.sub.2 receptors
    Patent number: 5212187
    Abstract: Arylalkylamine derivatives of the general formula ##STR1## are described which, owing to their anatagonistic action against histamine H.sub.1 - and H.sub.2 -receptors, can be used for the prophylaxis and treatment of disorders in which histamine is involved. They are prepared in a manner known per se.
    Type: Grant
    Filed: July 20, 1992
    Date of Patent: May 18, 1993
    Assignee: Zyma SA
    Inventors: Rudi A. Alisch, Frank R. Schulze, Armin Buschauer, Walter Schunack
  • Imidazolyl alkyl guanidine derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
    Patent number: 5021431
    Abstract: New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H.sub.2 receptors and in part also due to their additional H.sub.1 -antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion.
    Type: Grant
    Filed: February 28, 1989
    Date of Patent: June 4, 1991
    Assignee: Heumann Pharma GmbH & Co.
    Inventors: Armin Buschauer, Helmut Schickaneder, Walter Schunack, Sigurd Elz, Istvan Szelenyi, Gert Baumann, Kurt H. Ahrens
  • Guanidine carboxylic acid esters and pharmaceutical preparations containing these compounds
    Patent number: 4948802
    Abstract: New guanidine carboxylic acid esters corresponding to the general formula I ##STR1## and a process for the preparation of these compounds are described. The compounds according to the invention are H.sub.2 -agonists optionally having an additional H.sub.1 -antagonistic component. They are distinguished by their improved oral activity. The use of the above-mentioned guanidine carboxylic acid esters and of pharmaceutical preparations containing these esters is also described.
    Type: Grant
    Filed: April 11, 1988
    Date of Patent: August 14, 1990
    Assignee: Heumann Pharma GmbH & Co.
    Inventors: Peter Morsdorf, Helmut Schickaneder, Volker Pfahlert, Heidrun Engler, Armin Buschauer, Walter Schunack
  • Imidazolylguanidine derivatives and compositions containing these compounds
    Patent number: 4912119
    Abstract: New imidazolyl guanidine derivatives corresponding to the following general formula ##STR1## are described. These compounds may be used in cardiac diseases, certain forms of hypertension and in diseases of arterial occlusion on account of their agonistic action on histamine-H.sub.2 receptors and in part their additional H.sub.1 -antagonistic receptor activity.
    Type: Grant
    Filed: September 14, 1987
    Date of Patent: March 27, 1990
    Assignee: Heumann Pharma GmBH & Co.
    Inventors: Armin Buschauer, Helmut Schickaneder, Peter Morsdorf, Walter Schunack, Gert Baumann, Kurt-Henning Ahrens
  • 1,4-dihydropyridine derivatives
    Patent number: 4757080
    Abstract: New compounds which act on the cardiac circulation and correspond to the general formula ##STR1## and may be used for the treatment of cardiac diseases, in certain forms of hypertension and in diseases of arterial occlusion are described.Methods of preparation for these compounds and medicaments containing these compounds are also described.
    Type: Grant
    Filed: May 19, 1987
    Date of Patent: July 12, 1988
    Assignee: Heumann Pharma GmbH & Co.
    Inventors: Helmut Schickaneder, Peter Morsdorf, Armin Buschauer, Walter Schunack, Heidrun Engler, Hartmut Vergin, Kurt H. Ahrens